UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 67

Sortiert nach

Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis

Journal of cystic fibrosis, 2012-07, Vol.11 (4), p.288-292

2012

Link zum Volltext

Verfügbarkeit prüfen

68 #questionCF – the use of social media to engage the CF community in research

Journal of cystic fibrosis, 2017-06, Vol.16, p.S81-S82

2017

Link zum Volltext

Verfügbarkeit prüfen

64 Differences in research priorities within the CF community

Journal of cystic fibrosis, 2017-06, Vol.16, p.S80-S81

2017

Link zum Volltext

Verfügbarkeit prüfen

The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: A randomised comparison

Journal of cystic fibrosis, 2016-07, Vol.15 (4), p.510-517

2016

Link zum Volltext

Verfügbarkeit prüfen

233 Gaps in the evidence for treatment decisions in cystic fibrosis: a systematic review

Journal of cystic fibrosis, 2016-06, Vol.15, p.S110-S110

2016

Link zum Volltext

Verfügbarkeit prüfen

63 TORPEDO-CF – completion of recruitment to trial of optimal regimen for eradication of new infection with Pseudomonas aeruginosa

Journal of cystic fibrosis, 2017-06, Vol.16, p.S80-S80

2017

Link zum Volltext

Verfügbarkeit prüfen

WS20.1 Secular trends in Pseudomonas aeruginosa acquisition in the United Kingdom: a registry study

Journal of cystic fibrosis, 2016-06, Vol.15, p.S31-S31

2016

Link zum Volltext

Verfügbarkeit prüfen

287 Perception of first infection with Pseudomonas aeruginosa by people with CF, their families and close friends

Journal of cystic fibrosis, 2015-06, Vol.14, p.S131-S131

2015

Link zum Volltext

Verfügbarkeit prüfen

313 An international study of survival of children with cystic fibrosis after the first episode of invasive mechanical ventilation

Journal of cystic fibrosis, 2015-06, Vol.14, p.S138-S138

2015

Link zum Volltext

Verfügbarkeit prüfen

WS6.9 Urinary kidney injury molecule-1 is superior to creatinine and cystatin-C based formulas at predicting chronic kidney disease in patients with cystic fibrosis

Journal of cystic fibrosis, 2013-06, Vol.12, p.S13-S13

2013

Link zum Volltext

Verfügbarkeit prüfen

WS14.2 Surviving and thriving in the airway: how the arginine specific autotransporter aminopeptidase could promote the success of Pseudomonas aeruginosa in the CF lung

Journal of cystic fibrosis, 2016-06, Vol.15, p.S23-S23

2016

Link zum Volltext

Verfügbarkeit prüfen

232 Preliminary findings of a study comparing Incremental Step Test (IST) performance and physical activity levels in children with CF

Journal of cystic fibrosis, 2013-06, Vol.12, p.S107-S107

2013

Link zum Volltext

Verfügbarkeit prüfen

231 How active are CF children? Assessing physical activity levels at annual review

Journal of cystic fibrosis, 2013-06, Vol.12, p.S107-S107

2013

Link zum Volltext

Verfügbarkeit prüfen

181 The use of a rationalised antibiotic susceptibility testing protocol for children with cystic fibrosis and chronic Pseudomonas aeruginosa infection

Journal of cystic fibrosis, 2013-06, Vol.12, p.S94-S94

2013

Link zum Volltext

Verfügbarkeit prüfen

EPS1.9 Question CF: a James Lind Alliance Priority Setting Partnership in cystic fibrosis

Journal of cystic fibrosis, 2017-06, Vol.16, p.S38-S38

2017

Link zum Volltext

Verfügbarkeit prüfen

Guideline on the design and conduct of cystic fibrosis clinical trials: The European Cystic Fibrosis Society–Clinical Trials Network (ECFS-CTN)

Journal of cystic fibrosis, 2011-06, Vol.10, p.S67-S74

2011

Link zum Volltext

Verfügbarkeit prüfen

332 Pulmonary status does not predict school attendance in children with CF

Journal of cystic fibrosis, 2013-06, Vol.12, p.S133-S133

2013

Link zum Volltext

Verfügbarkeit prüfen

WS2.4 Use of non-prescribed medicines, supplements and therapies by children with cystic fibrosis, other chronic illnesses and children with an acute injury – A comparative mixed-methods study

Journal of cystic fibrosis, 2013-06, Vol.12, p.S3-S3

2013

Link zum Volltext

Verfügbarkeit prüfen

341 Do too few children with cystic fibrosis participate in clinical research?

Journal of cystic fibrosis, 2012-06, Vol.11, p.S144-S144

2012

Link zum Volltext

Verfügbarkeit prüfen

Delayed publication of clinical trials in cystic fibrosis

Journal of cystic fibrosis, 2012-01, Vol.11 (1), p.14-17

2012

Link zum Volltext

Verfügbarkeit prüfen

304 Premature vascular ageing in children with cystic fibrosis (CF)

Journal of cystic fibrosis, 2013-06, Vol.12, p.S126-S126

2013

Link zum Volltext

Verfügbarkeit prüfen

340 Is cystic fibrosis survival improving in excess to that of the general population for England and Wales and the USA?

Journal of cystic fibrosis, 2012-06, Vol.11, p.S144-S144

2012

Link zum Volltext

Verfügbarkeit prüfen

WS17.6 Phase 3 trial of inhaled levofloxacin (Aeroquin™, MP-376, APT-1026) vs. tobramycin inhalation solution (TIS) in intensively treated CF patients over 6 months

Journal of cystic fibrosis, 2013-06, Vol.12, p.S35-S35

2013

Link zum Volltext

Verfügbarkeit prüfen

WS23.6 Assessment of renal function in cystic fibrosis patients by estimated and measured glomerular filtration rate – a cross-sectional study

Journal of cystic fibrosis, 2012-06, Vol.11, p.S52-S52

2012

Link zum Volltext

Verfügbarkeit prüfen

The development and validation of the incremental step test (IST) in children with cystic fibrosis (CF)

Journal of cystic fibrosis, 2010, Vol.9, p.S69-S69

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(65)
Buchkapitel
(2)

Sprache

Englisch
(67)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis

68 #questionCF – the use of social media to engage the CF community in research

64 Differences in research priorities within the CF community

The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: A randomised comparison

233 Gaps in the evidence for treatment decisions in cystic fibrosis: a systematic review

63 TORPEDO-CF – completion of recruitment to trial of optimal regimen for eradication of new infection with Pseudomonas aeruginosa

WS20.1 Secular trends in Pseudomonas aeruginosa acquisition in the United Kingdom: a registry study

287 Perception of first infection with Pseudomonas aeruginosa by people with CF, their families and close friends

313 An international study of survival of children with cystic fibrosis after the first episode of invasive mechanical ventilation

WS6.9 Urinary kidney injury molecule-1 is superior to creatinine and cystatin-C based formulas at predicting chronic kidney disease in patients with cystic fibrosis

WS14.2 Surviving and thriving in the airway: how the arginine specific autotransporter aminopeptidase could promote the success of Pseudomonas aeruginosa in the CF lung

232 Preliminary findings of a study comparing Incremental Step Test (IST) performance and physical activity levels in children with CF

231 How active are CF children? Assessing physical activity levels at annual review

181 The use of a rationalised antibiotic susceptibility testing protocol for children with cystic fibrosis and chronic Pseudomonas aeruginosa infection

EPS1.9 Question CF: a James Lind Alliance Priority Setting Partnership in cystic fibrosis

Guideline on the design and conduct of cystic fibrosis clinical trials: The European Cystic Fibrosis Society–Clinical Trials Network (ECFS-CTN)

332 Pulmonary status does not predict school attendance in children with CF

WS2.4 Use of non-prescribed medicines, supplements and therapies by children with cystic fibrosis, other chronic illnesses and children with an acute injury – A comparative mixed-methods study

341 Do too few children with cystic fibrosis participate in clinical research?

Delayed publication of clinical trials in cystic fibrosis

304 Premature vascular ageing in children with cystic fibrosis (CF)

340 Is cystic fibrosis survival improving in excess to that of the general population for England and Wales and the USA?

WS17.6 Phase 3 trial of inhaled levofloxacin (Aeroquin™, MP-376, APT-1026) vs. tobramycin inhalation solution (TIS) in intensively treated CF patients over 6 months

WS23.6 Assessment of renal function in cystic fibrosis patients by estimated and measured glomerular filtration rate – a cross-sectional study

The development and validation of the incremental step test (IST) in children with cystic fibrosis (CF)

Suchergebnisse filtern